{"transactions":[{"id":712238,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-09T23:17:50.000Z","date":"2026-07-09","kind":"sale","planned":false,"acquired":false,"shares":12606,"price":6.9637,"value":87784.4022,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":290623,"source":{"system":"sec-edgar","filing":"0001493152-26-032740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226032740/ownership.xml","form_type":"4"}},{"id":735261,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:30:22.000Z","date":"2026-06-16","kind":"other","planned":false,"acquired":false,"shares":222,"price":5.67,"value":1258.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards."}],"balance_after":303229,"source":{"system":"sec-edgar","filing":"0001493152-26-029092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226029092/ownership.xml","form_type":"4"}},{"id":745555,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:53.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":5450,"price":5.3042,"value":28907.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":303451,"source":{"system":"sec-edgar","filing":"0001493152-26-028021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028021/ownership.xml","form_type":"4"}},{"id":745554,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T00:32:53.000Z","date":"2026-06-08","kind":"sale","planned":false,"acquired":false,"shares":4170,"price":5.4295,"value":22641.015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":308901,"source":{"system":"sec-edgar","filing":"0001493152-26-028021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226028021/ownership.xml","form_type":"4"}},{"id":785840,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-11T22:36:46.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":5548,"price":5.9613,"value":33073.2924,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.90 to $6.00 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":313071,"source":{"system":"sec-edgar","filing":"0001493152-26-022332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226022332/ownership.xml","form_type":"4"}},{"id":931689,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:35:36.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":12610,"price":5.2861,"value":66657.721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.35 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":318619,"source":{"system":"sec-edgar","filing":"0001493152-26-003611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003611/ownership.xml","form_type":"4"}},{"id":931688,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":31325,"kind":"person","name":"Vasanthavada Madhav","position":1,"cik":"0002106295","reported_name":"Vasanthavada Madhav","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:35:36.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":76621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029"}],"balance_after":331229,"source":{"system":"sec-edgar","filing":"0001493152-26-003611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003611/ownership.xml","form_type":"4"}}]}